Berzosertib Active Not Recruiting Phase 2 Trials for Castration-Resistant Prostate Carcinoma / Stage IV Prostate Cancer AJCC v8 / metastatic Carcinoma of the Prostate Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03517969M6620 and Carboplatin With or Without Docetaxel in Treating Patients With Metastatic Castration-Resistant Prostate Cancer